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TNFα promotes CAR-dependent 
migration of leukocytes across 
epithelial monolayers
Penny E. Morton1,*, Alexander Hicks2,*, Elena Ortiz-Zapater2, Swetavalli Raghavan1, 
Rosemary Pike1, Alistair Noble2, Abigail Woodfin3, Gisli Jenkins4, Emma Rayner5, 
George Santis2,* & Maddy Parsons1,*
Trans-epithelial migration (TEpM) of leukocytes during inflammation requires engagement with receptors 
expressed on the basolateral surface of the epithelium. One such receptor is Coxsackie and Adenovirus 
Receptor (CAR) that binds to Junctional Adhesion Molecule-like (JAM-L) expressed on leukocytes. 
Here we provide the first evidence that efficient TEpM of monocyte-derived THP-1 cells requires and is 
controlled by phosphorylation of CAR. We show that TNFα acts in a paracrine manner on epithelial cells 
via a TNFR1-PI3K-PKCδ pathway leading to CAR phosphorylation and subsequent transmigration across 
cell junctions. Moreover, we show that CAR is hyper-phosphorylated in vivo in acute and chronic lung 
inflammation models and this response is required to facilitate immune cell recruitment. This represents a 
novel mechanism of feedback between leukocytes and epithelial cells during TEpM and may be important 
in controlling responses to pro-inflammatory cytokines in pathological settings.
The epithelium plays a complex and active role in a wide range of biological processes such as embryonic develop-
ment, tissue homeostasis, wound healing and inflammation1,2. The migration of leukocytes across the epithelium 
is critical to elicit efficient tissue immune responses. Transmigration is a complex multi-step process that requires 
multiple interactions between transmembrane proteins on both leukocytes and epithelial cells to enable adhesion, 
transmigration and release into the luminal space3,4. Tight and adherens junctions are responsible for maintaining 
epithelial integrity by providing a link between adjacent epithelial cells; they are also important for interactions 
with immune cells and regulate their controlled passage across the epithelium5–7. Indeed, disruption of these 
cell-cell junctions has been associated with inflammatory diseases such as asthma8.
Coxsackie and Adenovirus (Ad) Receptor (CAR) was initially identified as the primary docking receptor 
for Coxsackie B viruses and members of the Ad family9. Further work has since demonstrated that CAR is an 
important cell adhesion molecule10,11 and a member of the Junction Adhesion Molecule (JAM) family that forms 
homo-dimers across cell-cell junctions12,13. We have recently shown that CAR is phosphorylated at S290/T293 
by PKCδ and this controls E-Cadherin stability at adherens junctions14,15. This function of CAR appears to be 
tissue-specific as CAR knockout mice have defects in lymphatic vessels16, lung and heart but not within the 
intestinal epithelium17. CAR has also been shown to bind to another of the JAM family proteins, JAM-L, that is 
expressed on the surface of leukocytes and this facilitates leukocyte transmigration and activation3,18–20. However, 
it remains unclear whether CAR:JAM-L triggers changes in the epithelial cell junction to facilitate TEpM, and if 
so, what external cues are responsible for initiating these changes.
Here, we have tested our hypothesis that CAR plays an active role in TEpM of leukocytes under inflammatory 
conditions. Our data demonstrates that phosphorylation of the cytoplasmic tail of CAR is required for efficient 
leukocyte TEpM and that CAR is phosphorylated both in vitro and in vivo specifically in response to TNFα and 
through a PI3K and PKCδ pathway. This data reveals a key novel role for CAR in leukocyte TEpM in inflamma-
tory conditions.
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Results
Phosphorylation of CAR is required for transmigration of THP-1 cells. CAR has previously been 
shown to be a receptor for JAM-L that is expressed on opposing membranes of leukocytes and required for 
transmigration across cell monolayers18. To test the hypothesis that phosphorylation of CAR may be involved 
in leukocyte transmigration, THP-1 cells (that are known to express JAM-L;21) were incubated with control or 
CAR-GFP over-expressing human bronchial epithelial cells (HBEC) that we have previously characterised15 and 
left to transmigrate for 48 hours. Overexpression of CAR-GFP significantly increased THP-1 cell transmigration 
through, but not adhesion to, the epithelial layer (Fig. 1A,B). Pre-incubation of cells with recombinant Ad5 fibre 
knob (FK) which binds to CAR with higher affinity than CAR binds to itself (Kirby et al.22), inhibited THP-1 
transmigration but had no effect on THP-1 cell adhesion to the epithelial monolayer (Fig. 1A,B). This data sug-
gests that THP-1 cell migration, but not adhesion might be dependent on the ability of CAR to homo-dimerise in 
trans. Alternatively, as the binding sites on CAR for JAM-L and FK overlap18,20,22, FK may inhibit THP-1 transmi-
gration by competitively blocking THP-1 cells binding to CAR at cell-cell junctions.
HBEC express low levels of endogenous CAR15, so we additionally tested the role of CAR in TEpM using an 
alternative well-characterised human bronchial epithelial cell line, 16HBE14-o. These cells express relatively high 
endogenous levels of CAR compared to HBEC and were therefore amenable to shRNA-mediated CAR knock-
down (Supp Fig. 1A). In support of our findings in HBEC, THP-1 cell transmigration was significantly reduced 
through monolayers of 16HBE14-o CAR knockdown cells (Fig. 1C). Leukocytes migrate through epithelia in a 
basal to apical direction therefore we analysed CAR dependent TEpM using a more physiological inverted trans-
migration assay where THP-1 adhere to the basal surface of the epithelial monolayer before migrating towards the 
apical surface. Figure 1D shows that expression of CAR-GFP significantly increased the number of THP-1 able to 
fully migrate to the apical surface of the HBEC monolayer (Fig. 1D) compared with wild-type (WT) cells. Finally, 
we tested whether CAR could also facilitate TEpM of primary monocytes and neutrophils isolated from human 
blood, both of which express high levels of JAM-L23. Data demonstrated that both cell types showed significantly 
higher transmigration through HBEC overexpressing CAR-GFP compared to WT cells (Fig. 1E) in agreement 
with our THP-1 cell line data. These data collectively demonstrate that monocytic cell binding to epithelial cells is 
facilitated through CAR and that this association is required for efficient trans-epithelial migration.
THP-1 cells stimulate CAR phosphorylation, which is required for transmigration. Our recent 
discovery that CAR can be phosphorylated at cell-cell junctions15 prompted us to examine CAR phosphoryl-
ation status during THP-1 integration and transmigration. THP-1 cell interactions with CAR-GFP HBEC led 
to a prolonged increase in phospho-CAR that peaked at around 4–8 h post THP-1 addition (Fig. 2A), and this 
peak correlated with the time taken for THP-1 to fully integrate into HBEC monolayers. The p-CAR signal we 
detected was specific to CAR expressed in HBEC as THP1 cells do not express detectable levels of CAR (data not 
shown). Treatment of CAR-GFP cells with soluble JAML protein did not induce CAR phosphorylation, imply-
ing that CAR ligation alone is not sufficient for this activation step (data not shown). THP-1 cell-induced CAR 
phosphorylation was inhibited by pre-treatment of cells with FK (Fig. 2B) or function blocking CAR antibody 
RMCB (Fig. 2C) further demonstrating that THP-1-CAR binding was required for CAR phosphorylation to 
occur. Antibody-induced crosslinking of CAR-GFP HBEC was not able to induce CAR phosphorylation (data 
not shown), further suggesting that the presence of THP-1 cells and potentially other signals are required for 
phosphorylation to occur.
To investigate whether the observed increase in phospho-CAR played a role in TEpM, we analysed transmi-
gration across HBEC expressing phospho-mimic (DDCAR-GFP) or phospho-dead (AACAR-GFP) CAR-GFP 
that localise similarly to cell-cell junctions as compared to CAR-GFP (Supp Fig. 1B;15). Data demonstrated that 
expression of DDCAR-GFP but not AACAR-GFP supported enhanced THP-1 transmigration across HBEC 
despite equal levels of CAR-GFP being expressed in these cell lines (Fig. 2D,E). Expression of AACAR-GFP 
and DDCAR-GFP had no effect on epithelial monolayer permeability under unstimulated conditions compared 
to wild-type HBEC or those expressing CAR-GFP (Supp Fig. 1C). Expression of another key surface receptor 
molecule involved in leukocyte transmigration, Intercellular Adhesion Molecule-1 (ICAM1), was unchanged 
upon CAR overexpression in 16HBE cells or treatment with TNFα (Supp Fig. 1D). However, ICAM1 levels were 
slightly elevated in HBEC expressing AACAR compared to those expressing FLCAR (Supp Fig. 1D). The mech-
anisms or consequences of the increased ICAM1 expression specifically in phospho-dead expressing CAR cells 
remains unknown, but given that ICAM1 is a positive regulator of TEM, this data strongly implies that changes in 
ICAM1 do not contribute to altered TEM seen in cells overexpressing CAR. Confocal analysis and quantitation 
further revealed that CAR-GFP and DDCAR-GFP but not AACAR-GFP was clustered around transmigrating 
THP-1 cells (Fig. 2F,G). Combined, this data demonstrates that CAR is required for efficient transmigration of 
leukocytes and this is promoted by phosphorylation of the CAR cytoplasmic tail.
TNFα stimulates CAR phosphorylation via PI-3-K and PKCδ. Pro-inflammatory cytokines play an 
important role in mediation of leukocyte transmigration24 and have been shown to regulate JAM family pro-
tein localisation and function25–28. We therefore hypothesised that CAR phosphorylation may be driven by a 
cytokine-induced signalling pathway. Treatment of cells with a panel of pro-inflammatory cytokines TNFα , 
IL-5, IL-1β , IL-13 and IL-1725,27–29 revealed that TNFα treatment induced a robust increase in phospho-CAR 
in CAR-GFP but not AACAR-GFP expressing HBEC (Fig. 3A). TNFα treatment also induced significant phos-
phorylation of endogenous CAR in 16HBE cells (Supp Fig. 1E). Moreover, TNFα -induced phosphorylation of 
CAR was inhibited by pre-treatment of cells with Ad5FK suggesting that CAR homo-dimerisation was required 
for this response to stimulation (Fig. 3A). Confocal analysis further revealed that TNFα -induced CAR phos-
phorylation occurred predominantly at cell-cell junctions supporting the notion that homo-dimerised CAR 
in trans is required for CAR phosphorylation downstream of TNFα (Fig. 3B). IL-5 also induced modest CAR 
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Figure 1. CAR promotes transmigration of leukocytes across human bronchial epithelial cell monolayers. 
(A) THP-1 cells were stained using cell-tracker orange before adding to the top well of transwell inserts 
containing WT or CAR-GFP HBEC monolayers and pre-treated with BSA (control) or recombinant fibre 
knob protein (FK). THP-1 cells in the bottom well were counted after 24 hours using FACS. Data is presented 
as relative fold change of THP-1 cell number transmigration (TEM) compared to WT control conditions from 
4 independent experiments + /− SEM. (B) Quantification of THP-1 adhesion to WT or CAR-GFP HBEC. 
Experiments were set-up as in (A) and number of adhered THP-1 cells to the HBEC monolayer assessed after 
24 hours. Data is representative of four independent experiments; mean values from n = 4 wells + /− SEM.  
(C) THP-1 cells were labelled using cell-tracker orange before adding to the top of transwell inserts containing 
monolayers of 16HBE14-o cells stably expressing control (scrambled) or CAR-targeted shRNA. THP-1 cells in 
the bottom well were counted after 24 hours using FACS. Data is presented as relative fold change of THP-1 cell 
number compared to WT control conditions from 4 independent experiments + /− SEM. (D) THP-1 cells were 
added to the underside of transwell inserts containing monolayers of WT or CAR-GFP-HBEC and allowed to 
adhere before inserts were inverted for 8 hours in the presence of a serum gradient to allow baso-lateral to apical 
migration of THP-1 cells. Data is representative of four independent experiments and presented as relative fold 
change of THP-1 cell number compared to WT control conditions from 4 wells + /− SEM. (E) Transmigration 
of primary human neutrophils and monocytes was analysed using Transwell chambers containing monolayers 
of WT and CAR-GFP-HBEC as in (A). Data is presented as relative fold change of THP-1 cell number compared 
to WT control conditions from 4 independent experiments + /− SEM.
www.nature.com/scientificreports/
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Figure 2. CAR promotes THP-1 transmigration in a phosphorylation dependent manner. (A) THP-1 
cells were added to CAR-GFP HBEC monolayers for the times indicated. Cells were then lysed and 
immunoprecipitated with anti-GFP antibodies followed by western blotting using antibodies against p-CAR, 
and GFP. Total cell lysates were probed for E-cadherin and HSP-70 as loading controls. Calyculin A (CalA) 
treatment was used as a positive control to induce p-CAR. Values beneath blots are relative levels of p-CAR 
compared to time 0 from 4 independent experiments + /− SEM. (B) Western blot of phosphorylated CAR as 
in (A) following 4 h incubation with THP-1 cells with or without pre-treatment with 100 μ g/ml FK or BSA 
as a control. Values beneath blots are relative levels of p-CAR compared to untreated from 4 independent 
experiments + /− SEM. (C) Western blot of phosphorylated CAR as in (A) following 4 h incubation with THP-1 
cells with or without pre-treatment with 10 μ g/ml RMCB CAR function blocking antibody or IgG as a control. 
Values beneath blots are relative levels of p-CAR compared to untreated from 4 independent experiments + /− 
SEM. (D) THP-1 transmigration analysis performed as in (A) using WT, CAR-GFP, AACAR-GFP and 
DDCAR-GFP HBEC. Error bars are SEM. Statistical significance compared with CAR-GFP HBEC is shown. (E) 
Representative western blot of levels of CAR-GFP in specified cells lines. (F) Example confocal images of THP-1 
cells undergoing trans-epithelial migration. Cell tracker orange stained THP-1 cells were added to confluent 
monolayers of HBEC and fixed after 24 hours before confocal imaging to obtain z-stacks. Cell tracker orange 
THP-1 cells (blue), CAR-GFP (green) and actin (red) to show the position of the HBEC are shown. Z-slice and 
maximum intensity projection show the location of THP-1 in relation to HBEC monolayer and recruitment 
of CAR-GFP to THP-1. (G) Quantification of % of cells with lateral associated CAR-GFP in images as from 
(F) Data is mean of 18 fields of view over 3 independent experiments. For all data where relevant * = p < 0.005 
compared to CAR-GFP.
www.nature.com/scientificreports/
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Figure 3. TNFα stimulates CAR phosphorylation downstream of P-I-3K and PKCδ. (A) Western blot 
analysis of CAR-GFP HBEC treated with 10 ng/ml TNFα (60 min) and 200 μ g/ml FK (120 min) or BSA control 
as indicated, probed for phospho-CAR and GAPDH as a loading control. Values beneath blots are relative levels 
of p-CAR compared to time 0 from 4 independent experiments + /− SEM. (B) Confocal images of CAR-GFP 
HBEC or AACAR-GFP HBEC mixed 1:1 with WT HBEC treated with 10 ng/ml TNFα and immunostained for 
phospho-CAR. Arrows indicate increased phospho-CAR at junctions following treatment with TNFα . Images 
are maximum intensity projections of z-stacks through the entire z-depth of the cells acquired using identical 
Z-depth acquisition settings. Scale bars are 10 μ m. (C) Confocal images of endogenous TNFR1 (red) localisation 
in a 1:1 WT:CAR-GFP (green) HBEC mix untreated cells or treated with 10 ng/ml TNFα for 60 min. White 
boxes are highlighted inset panels below. (D) Western blot analysis of phospho-CAR and phospho-PKCδ after 
treatment with 10 ng/ml TNFα for the indicated times. Western blots were also probed for GAPDH as a loading 
control. Calyculin A was used as a positive control. Values beneath blots are relative levels of p-CAR compared 
to untreated from 4 independent experiments + /− SEM. * = p < 0.01. (E) Western blot analysis of phospho-
www.nature.com/scientificreports/
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phosphorylation but to a much lesser extent compared with TNFα (Supp Fig. 1F). None of the other cytokines 
tested induced CAR phosphorylation (Supp Fig. 1G). We therefore explored the co-operation between TNFα and 
CAR in more detail.
TNFα signals predominantly through TNF receptor1 (TNFR1) in epithelial cells, so we postulated that CAR 
and TNFR1 might be able to form a complex at the membrane in the presence of inflammatory cues. However, 
confocal imaging revealed that whilst both TNFR1 and CAR were present at CAR-GFP HBEC cell-cell junctions 
and CAR-GFP expression did not affect TNFR1 protein levels (Supp Fig. 1H), the two receptors did not show sig-
nificant colocalisation (Fig. 3C) suggesting that CAR may potentially relocalise distribution of TNFR1 within the 
plasma membrane. We have previously shown that CAR is phosphorylated by PKCδ 15 and this kinase is also acti-
vated downstream of TNFα -TNFR1 binding and PI-3-kinase (PI-3-K) in neutrophils18. To determine whether 
this pathway was important in control of CAR phosphorylation, we analysed levels of active PKCδ in the same 
samples as p-CAR following TNFα treatment. Western blot analysis demonstrated that TNFα induced PKCδ 
activity in HBEC and this correlated with the time-course of CAR phosphorylation in the same samples (Fig. 3D). 
Moreover, siRNA mediated depletion of PKCδ or inhibition of PI-3-K by treatment with LY294002 both inhibited 
TNFα -induced CAR phosphorylation (Fig. 3E,F) supporting a role for this pathway in CAR-dependent induction 
of TEpM.
TNFα induced CAR phosphorylation promotes TEpM of THP-1 cells. TNFα is known to affect the 
stability and structure of endothelial cell junctions to promote trans-endothelial migration of leukocytes during 
inflammation24,26. We therefore postulated that TNFα could promote TEpM of leukocytes through phosphoryl-
ation of CAR. We first sought to clarify whether TNFα could promote integration of leukocytes within epithelial 
monolayers, and whether this was CAR-dependent. Our analysis revealed that CAR-GFP HBEC monolayers 
stimulated with 10 ng/ml TNFα showed significantly higher THP-1 integration after 4 hours than untreated mon-
olayers (Fig. 4A). Moreover, WT HBEC (that express very low levels of CAR) and AACAR-GFP-HBEC did not 
exhibit an increase in THP-1 integration when treated with TNFα (Fig. 4A). Thus phosphorylation of CAR is 
required for TNFα -induced transmigration of THP-1 cells.
THP-1 cells have previously been shown to secrete TNFα 30 so we next investigated whether THP-1 may act in 
a paracrine fashion to promote transmigration through HBEC. Pre-incubation of CAR-GFP HBEC with TNFR1 
blocking antibodies, at a concentration that completely blocked TNFα induced TNFR1 activation (Supp Fig. 1I), 
resulted in reduced THP-1 integration into CAR-GFP HBEC monolayers (Fig. 4B) thus confirming a requirement 
for TNFR1 in this process. Moreover, blocking TNFR1 function also inhibited both TNFα - and THP-1 induced 
CAR phosphorylation (Fig. 4C,D) further demonstrating a requirement for TNF-TNFR1 engagement in con-
trolling CAR phosphorylation. Taken together these data show that THP-1 cells induce CAR phosphorylation in 
epithelial cells via TNFR1 to promote their integration.
We next sought to understand whether CAR phosphorylation and TNFα might facilitate increased THP-1 
TEpM by analysing the stability of junction dynamics in HBEC expressing CAR-GFP and AACAR-GFP. 
Time-lapse confocal imaging of HBEC revealed that in the absence of stimulation, CAR-GFP and AACAR-GFP 
positive cell-cell junctions exhibited similar predominantly stable cell-cell contacts (Fig. 4E, quantified in F). 
However after addition of TNFα , CAR-GFP positive junctions became more dynamic, exhibiting increased 
instability, discontinuity and movement of cell-cell interfaces within the monolayer (Fig. 4E, top left panels). 
In contrast, AACAR-GFP positive junctions showed minimal change in dynamic behaviour following TNFα 
stimulation (Fig. 4E, bottom left panels, and 4F). Moreover, analysis of FITC-dextran permeability assays over the 
same time periods of TNF treatment demonstrated a significant increase in CAR-GFP cell permeability but not 
in AACAR-GFP expressing cells (Supp Fig. 1J). These data support a role for CAR phosphorylation in the control 
of cell-cell junction dynamics.
Inflammatory signals trigger CAR phosphorylation and leukocyte recruitment to the bronchial 
epithelium. TNFα is known to promote leukocyte trans-endothelial migration26 as well as epithelial mon-
olayer stability (Coyne et al.5) and may therefore function as key mediator of CAR function during inflammation 
in vivo. We addressed this hypothesis using two different mouse models of lung inflammation. Firstly, we assessed 
levels of CAR phosphorylation in a murine model of TNFα -induced acute lung inflammation. Analysis of sec-
tions of lung epithelium following intra-tracheal TNFα challenge for 24 hours resulted in an increase in CAR 
phosphorylation at junctions between small airway epithelial cells without affecting total CAR levels or localisa-
tion (Fig. 5A) as well a recruitment of immune cells to the bronchial epithelium (Supp Fig. 2A). Secondly, we ana-
lysed CAR phosphorylation in an ovalbumin-induced chronic lung inflammation model. Under these conditions, 
chronic inflammation also induced CAR phosphorylation, specifically at cell-cell junctions of small bronchioles 
(Fig. 5B) as well a recruitment of immune cells to the bronchial epithelium (Supp Fig. 2B). Importantly, repeating 
the same challenge in TNFR knockout mice resulted in no effect on CAR phosphorylation, suggesting that TNF 
can trigger CAR phosphorylation via a TNFR1-driven pathway in vivo (Fig. S2C,D). This data shows that CAR 
CAR in CAR-GFP HBEC transfected with PKCδ siRNA or non-targeting control (NT). Cells were treated with 
10 ng/ml TNFα for 60 min where indicated. Western blots were probed for phospho-CAR, PKCδ and GAPDH 
as a loading control. Values beneath blots are relative levels of p-CAR compared to untreated NT siRNA from 3 
independent experiments + /− SEM. (F) Western blot analysis of phospho-CAR and phospho-PKCδ after pre-
treatment with 10 μ M LY294002 for 2 hours where indicated and further treatment with 10 ng/ml TNFα for the 
times shown. Western blots were also probed for GAPDH as a loading control. Values beneath blots are relative 
levels of p-CAR compared to untreated from 3 independent experiments + /− SEM.
www.nature.com/scientificreports/
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Figure 4. TNFα promotes THP-1 integration into epithelial layers in a phospho-CAR dependent manner. 
(A) Analysis of THP-1 integration into WT, CAR-GFP or AACAR-GFP HBEC monolayers 4 hours after 
addition of THP-1. Where indicated, HBEC cultures were pre-treated with 10 ng/ml TNFα for 1 hour prior to 
addition of THP-1. (B) Analysis of THP-1 integration into WT, CAR-GFP or AACAR-GFP HBEC monolayers 
6 hours after addition of THP-1. Where indicated, HBEC cultures were pre-treated with 10 μ g/ml anti-TNFR1 
blocking antibody or an isotype specific control antibody, for 1 hour prior to addition of THP-1. For both A 
and B, statistical significance compared with untreated control is shown. (C) Western blot analysis of phospho-
CAR in CAR-GFP HBEC treated with 10 ng/ml TNFR1 blocking antibody or a control antibody, and further 
treated with 10 ng/ml TNFα where indicated. GADPH was used as a loading control. (D) Western blot analysis 
of phospho-CAR in CAR-GFP HBEC cultured with THP-1 cells for 4 hours. Where indicated, CAR-GFP 
HBEC were treated with 10 μ g/ml TNFR1 blocking antibody prior to addition of THP-1. GADPH was used as 
a loading control. Values beneath blots are relative levels of p-CAR compared to untreated from 4 independent 
www.nature.com/scientificreports/
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phosphorylation and neutrophil recruitment into the broncho-alveolar spaces occur over a similar time frame 
during inflammation. Moreover, exogenously applied TNFα stimulates CAR phosphorylation and promotes 
migration of leukocytes in the bronchial lumen. This would suggest that heightened TNFα levels such as those 
found during inflammation might drive CAR-dependent immune cell integration into epithelial tissues in vivo.
Our data showed that pre-incubation of CAR-GFP HBEC cells with FK successfully blocked TNFα mediated 
CAR phosphorylation (Fig. 3B). In order to investigate whether this may also be the case in vivo, FK was deliv-
ered into mice via intra-tracheal administration followed by challenge with TNFα . Western blot and immuno-
histochemistry analysis revealed that administration of FK significantly reduced CAR phosphorylation both in 
whole lungs (Fig. 5C) and lung sections (Fig. 5E) respectively. Moreover, bronchial lavage of these mice showed 
significant TNFα -induced bronchial egression of neutrophils (Fig. 5D), which have previously been shown to 
utilise CAR:JAM-L interactions to undergo TEpM3. Importantly FK also blocked TNFα -stimulated neutrophil 
egression, showing that TNFα stimulated neutrophil migration into the bronchial lumen is dependent on phos-
phorylated CAR in bronchial epithelial cells. Interestingly, in haematoxylin and eosin stained lung sections from 
the same mice we observed that FK did not decrease general recruitment of immune cells to the bronchiolar 
epithelium (Supp Fig. 2E). This indicates that the effect of inhibiting CAR phosphorylation may be specific to 
sub-sets of immune cells, possibly those expressing JAM-L such as neutrophils. Taken together these data demon-
strate the importance of inflammation-induced CAR phosphorylation in vivo.
Discussion
In this study we show that in trans homo-dimers of CAR within epithelial cell-cell adhesions are phosphoryl-
ated in response to exogenous TNFα and that this contributes to efficient transmigration of monocytes and 
neutrophils both in vitro and in vivo. Our data further suggests that CAR may be a novel important receptor in 
the control of inflammation downstream of TNFR1-dependent signalling and thus may represent an alternative 
therapeutic target in control of chronic inflammatory lung disease.
The data we present here shows that CAR is important in transmigration of leukocytes, but not initial adhe-
sion of these cells to the epithelial monolayer. CAR has been shown to be present in both tight and adherens junc-
tions, but is low or absent at the apical surface of polarised cell monolayers10,14,31,32. This lack of available CAR at 
the apical surface for JAM-L binding on leukocytes would suggest alternative adhesion molecules are involved in 
the initial leukocyte adhesion and tethering steps to the cell monolayer. Indeed, a number of epithelially expressed 
adhesion receptors including integrins and selectin family members have been shown to participate in this pro-
cess during inflammation33. Following adhesion, the leukocytes are then able to access CAR at tight and adherens 
junctions through JAM-L binding (shown in our current study and3,23) and this adhesion can promote subsequent 
transmigration. Whilst we do not directly demonstrate a requirement for the CAR-JAML interface in the present 
study, JAML is the only recognised receptor for CAR on leukocytes, strongly implying that this interaction is also 
required fro transmigration in our experimental system. In addition to interactions with epithelial cells, our study 
also points to a potential role for CAR in endothelial cells in mediating transmigration. CAR expression has been 
reported to be very low or absent in many human vascular endothelial cells studied to date, but CAR is expressed 
in bone microvascular23, neonatal lymphatic16 and cardiac endothelial tissue34. Expression in vessels from other 
origins remains unclear, but it is certainly feasible that CAR may play a role in some tissues in mediating local 
inflammation. This will be an interesting avenue to pursue in future studies. Our data also shows that expression 
of CAR in the epithelium enhances transmigration of primary neutrophils and monocytes in vitro and in vivo, as 
well as THP1 cells that are of monocytic origin. Whilst our current data does not distinguish between different 
populations of monocytes, our data strongly suggests that CAR promotes transmigration in the presence of high 
levels of TNFα. This would be in-line with the notion that CAR can promote transmigration of so-called classical 
or ‘inflammatory’ monocytes, as opposed to the non-classical ‘patrolling’ population and would further support 
a role for CAR in enhancing monocyte tissue infiltration during inflammatory conditions. Future experiments 
will focus on understanding whether CAR can also play a role in maintaining homeostatic inflammation in the 
lung in vivo using transgenic animals, as well as further investigating responses during specific lung insults such 
as allergens.
Our current data demonstrates that TNFR1-induces a PI-3-K/PKC signalling cascade which is a key con-
tributing pathway leading to CAR phosphorylation and leukocyte transmigration. It is not yet clear whether this 
PKC-induced phosphorylation event is able to induce a conformational change in the CAR ecto-domain such 
that JAM-L binding is more efficient. One possibility is that phosphorylation may induce later in cis interactions 
between CAR molecules that may promote more effective JAM-L binding. Indeed a similar mechanism has been 
shown for JAM-L binding to CAR23 and may suggest that interactions between receptors both in cis and in trans 
must be tightly spatially and temporally regulated in order to facilitate efficient ligand binding and permit migra-
tion. It is important to note that our data shows no change in basal permeability of the epithelial layer when FL 
or DDCAR are overexpressed, despite a significant increase in leukocyte transmigration across these cells. This 
further supports a model where receptor clustering and signalling crosstalk with the junctional components and 
actin cytoskeleton are tightly regulated via additional chemical and physical cues. Dissecting the biophysical 
changes that are required for CAR function during transmigration represents an important future challenge.
experiments + /− SEM. (E) Confocal time-lapse microscopy analysis of junction dynamics in CAR-GFP and 
AACAR-GFP HBEC prior and post addition of 10 ng/ml TNFα as indicated above images. Images are stills 
taken from the time-lapse movies. (F) Analysis of cell-cell junctions in images taken as in (E) CAR-GFP 
and AACAR-GFP HBEC positive junctions were characterised as shown and presented as percentage of the 
total; n = 90 junctions per condition over 3 different experiments. Where relevant, * = p < 0.05, ** = p < 0.01 
*** = p < 0.005.
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In summary, our data has identified a novel mechanism in which TNFα -dependent post-translational mod-
ification of CAR mediates efficient trans-epithelial migration of leukocytes. These findings implicate CAR as an 
important mediator of immune cell recruitment to sites of epithelial inflammation and a new potential therapeu-
tic target for drug design.
Materials and Methods
Antibodies and reagents. Anti-E-cadherin (HECD-1) antibody was from Invitrogen. Anti-CAR (H300), 
anti-TNFR1 (H5), anti-ICAM1 and anti-PKCδ antibodies were from Santa Cruz (Germany). Anti-phospho-
PKCδ was from Cell Signalling Technology (USA). p-CAR thr290/ser293 polyclonal antibody was previously 
described in Morton et al.15, and was developed by Perbioscience (Thermofisher) using the peptide Ac- RTS(pT)
Figure 5. TNFα promotes trans-epithelial migration of leukocytes in a CAR dependent manner in vivo. 
(A) Confocal analysis of fixed lung sections from C57BL/6 (B6) mice sensitized with 1 μ g recombinant murine 
TNFα in 50 μ l of PBS or PBS alone and immunostained separately for phospho-CAR (top) or total CAR 
(bottom). (B) Confocal analysis of lung sections from Ovalbumin stimulated (OVA) or PBS treated control 
mice. Sections were stained with phospho-CAR (top) or total CAR (bottom). (C) Western blot analysis of 
phospho-CAR in whole lung lysates from of C57BL/6 (B6) mice sensitized with 1 μ g recombinant murine TNFα 
and total CAR alone or pre-sensitized with 500 μ g FK as indicated. HSP-70 was used as a positive control. (D) 
BAL data from C57BL/6 (B6) mice sensitized with 1 μ g recombinant murine TNFα alone or pre-sensitized 
with 500 μ g FK as indicated. Data is pooled from four different mice + /− SEM and representative of two 
experiments. * = p < 0.001 compared to TNFα alone. (E) Confocal analysis of lung sections from experiments 
shown in C and D immunostained with phospho-CAR antibodies. Scale bars correspond to 20 μm.
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AR(pS)YIGSNH-C and was affinity purified before use. Anti-TNFR1 blocking antibody (Mab225) was obtained 
from R&D Systems (USA). Anti-GFP antibody was from Roche (UK). Anti-mouse HRP and anti-rabbit-HRP 
were from DAKO, anti-mouse-568, anti-rabbit-568 and phalloidin-633 were all obtained from Invitrogen (UK). 
CalyculinA, sodium orthovanadate and PI-3-kinase inhibitor (LY294002) were obtained from Calbiochem. 
TNFα , IL-5, IL-1β , IL-13 and IL-17 were obtained from Sigma-Aldrich (UK). FK was produced and purified as 
previously described35. PKCδ targeted siRNA and non-targeting controls were obtained from Ambion (USA).
Plasmids. Full length and mutant CAR sequences were cloned in frame into pHR9SIN-SEW lentiviral expres-
sion vector, which was a gift from Prof Adrian Thrasher (Institute of Child Health, UCL;36). Phospho-mutant CAR 
constructs were generated using site directed mutagenesis and have been described previously15. CAR shRNA vec-
tors were in pLKO.1 backbones purchased from Sigma Mission collection (clone ID NM_001338.3-781S21C1).
Cell culture. Immortalised human bronchial epithelial cells (HBEC) were a gift from Dr Jerry Shay (UT 
Southwestern37) and were grown in KSFM (Invitrogen). All CAR expressing stable cell lines and have been pre-
viously described15. 16HBE-o human bronchial epithelial cells were a gift from Prof D.Gruenert (University of 
Vermont, US;38) and were cultured in RPMI containing 10%FCS (Sigma, UK). THP-1 cells were a gift from Prof. 
G.E. Jones and Dr A Ivetic (King’s College London) and were maintained in RPMI supplemented with 10% FCS 
and 500 μ M β -Mercaptoethanol. HEK293 packaging cells were used to generate lentiviral particles for viral trans-
duction as previously described15.
Confocal microscopy. Cultured cells were washed with PBS, fixed with 4% PFA in PBS for 10 min and 
permeabilised with 0.2% TritonX-100 for 10 min. Cells were incubated with primary antibodies for 2 hours and 
appropriate secondary antibodies conjugated to alexafluo-568 or cy5 and Phalloidin conjugated to Alexafluor 
568 or 633 for 1 hour. Cells were mounted onto slides using Immunofluore (ICN, UK). Confocal microscopy was 
performed using a Nikon A1R inverted confocal laser scanning microscope with a 60x oil objective and laser 
excitation wavelengths of 488 nm (for GFP or Alexafluor-488), 561 nm (for Alexafluor-568) and 633 nm (for 
Alexafluor-633 and cy5).
For live cell imaging experiments, HBEC were plated onto glass-bottomed Ibidi chambers (Ibidi, Germany) 
and allowed to form an intact monolayer as determined using phase contrast microscopy. Cells were then imaged 
every minute using 488 nm laser excitation using a 60x oil objective on a Nikon A1R inverted confocal micro-
scope (Nikon UK) equipped with a humidified environmental chamber heated to 37 °C, with 5%CO2 and PFS 
activated. After 30 minutes, TNF was added to the imaging media at a final concentration of 10 ng/ml and the 
imaging immediately resumed every minute for a further 90 minutes. All images were saved as. nd2 files and 
analysed in NIS Elements software (Nikon) or exported as tif files for presentation. Analysis of live cell junctional 
dynamics was performed on exported image sequences using ImageJ. Individual cell-cell junctions were ran-
domly selected from the final frames of movies using a defined ROI (90 in total per condition and cell type). Using 
intensity linescans, junctions were classified as one of three phenotypes: ‘disassembled’: where no defined line of 
CAR-GFP was evident between two cells, ‘disconnected’: where an intermittent accumulation of CAR-GFP was 
present at the junction or ‘intact’: where a clear, dense accumulation of CAR-GFP was present as a single contin-
uous line. Data was pooled within each independent experiment and distributions plotted as shown in Fig. 4F.
Western blotting and immunoprecipitation. 100,000 HBEC per condition were cultured either in nor-
mal growth media lysis in 100 ul sample buffer containing β -mercaptoethanol at room temperature. Lysates were 
immediately subjected to SDS-PAGE and blotted using nitrocellulose membrane. Blots were blocked and probed 
using 3% milk/PBS-0.2%tween or 5%BSA/TBS-0.1%tween. For THP-1 co-culture experiments, HBEC media was 
replaced with THP-1 growth media minus β -mercaptoethanol 2 hours prior to THP-1 addition. Cells were then 
lysed and analysed as before. For IP experiments, CAR-GFP HBEC were cultured in growth media for 48 hours 
before treatment with CalA and lysis in IP lysis buffer (pH7.4 50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Triton, 
1% NP40, PI cocktail). Lysates were incubated with 5μ g anti-GFP antibody pre-bound to A/G agarose beads 
overnight before washing the beads with 1 ml IP lysis buffer 3 times. Immunocomplexes were separated using 
SDS-PAGE and immunoblotted for specified proteins.
Trans-epithelial migration assays. HBEC or 16HBE14-o cells were seeded in 6.5 mm Transwell cham-
bers (Corning, UK) with 8.0 μ m pores at 30,000 cells per chamber and allowed to form monolayers. Media in the 
upper and lower chambers was changed to RPMI containing 10% FBS before addition of 100,000 THP-1 cells, 
primary monocytes or primary neutrophils stained with Cell TrackerTM Orange Dye (Molecular probes, UK) 
were added to the top well of the chambers. After 24 hours, the number of THP-1 cells in the lower chamber was 
counted using a FACSCalibur flow cytometer (BD Biosciences). For Ad5 fibre-knob competition assays recombi-
nant Ad5FK or BSA control was added to HBEC cells 3 hours after seeding and remained in the media throughout 
the experiment. Data is presented as percentage of total cells added that underwent transmigration.
Inverted trans-epithelial migration assays. HBEC or 16HBE14-o cells were seeded in 6.5 mm 
Transwell chambers (Corning, UK) with 8.0μ m pores at 30,000 cells per chamber and allowed to form monolay-
ers. Transwell inserts were then inverted and 100,000 THP-1 stained with Cell TrackerTM Orange Dye (Molecular 
probes, UK) were added to the underside of the Transwells. The THP-1 cells were allowed to adhere for 1 hr before 
placing them back into the plate. To encourage TEpM against gravity RPMI containing 1% FBS as place into the 
lower chamber while RPMI containing 10% FBS was place in the upper chamber. After 24 hours the Transwell 
inserts were removed, fixed in PFA and stained with phalloidin. A total of 3 5 × 5 tile-scans per plane (basal 
surface, within the monolayer and apical surface) per sample were obtained using a 40x air objective on a Nikon 
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A1R inverted laser scanning confocal microscope. The tiles were assembled together using Nikon NIS Elements 
software and further analysed to count the number of THP-1 present within each level. Data presented is only 
THP-1 present on the apical surface of the HBEC monolayer. Data is presented as percentage of total cells added 
that underwent transmigration.
Isolation of primary human monocytes and neutrophils. Citrated blood (1 ml citrate/10 ml of 
blood) was collected from healthy volunteers in accordance with the locally approved ethical guidelines and fol-
lowing written informed consent from all subjects. Procedures were approved by Guy’s and St Thomas’ NHS 
Foundation Trust and King’s College London. Blood was gently inverted and diluted with equal quantity of MACS 
buffer (50 ml of 2% FBS-PBS and 0.2 ml of 0.5M of EDTA). The diluted blood was gently layered above 15 ml 
of Lymphoprep (Stemcell Technologies, USA) and after centrifugation (800 g, 20 min, without break) periph-
eral blood mononuclear cells (PBMCs) were collected and washed. Monocytes were negatively isolated from the 
PBMC population using the Monocyte Isolation Kit II (Miltenyi Biotec, USA) following manufacturer´s instruc-
tions. Evaluation of monocyte purity was achieved by incubating the cells for 30 minutes on ice with a viability 
dye (Live/dead Fixable Aqua, Life Technologies) followed by a second incubation using monoclonal antibodies: 
CD14-APC (61D3), CD16-PE (eBioCB16) from eBioscience. Streptavidin-PE/Cy5 (BD Pharmingen, UK) was 
added to check the possible contaminant cells. The acquisition was performed using an Attune NxT flow cytom-
eter (Life Technologies) and analysed with FlowJo v9.8 software (FlowJo, LLC). Neutrophils were isolated from 
freshly drawn anti-coagulated whole blood from healthy volunteers using the MACSxpress® Neutrophils Isolation 
Kit from Milteny Biotec following manufacturer´s instructions. Removal of residual erythrocytes was done using 
a Red Blood Cell Lysis Solution (Milteny Biotec, USA) and evaluation of neutrophil purity was performed using 
CD15-FITC (HI98), CD16-PE (eBioCB16) both from eBioscience and Streptavidin-PE/Cy5 (BD Pharmingen, 
UK) followed by acquisition in a Attune NxT flow cytometer (Life Technologies). A viability dye-Aqua (Life 
Technologies) was used in a previous incubation to exclude the dead cells. Analysis was performed using FlowJo 
v9.8 (FlowJo, LLC) software. Transmigration assays were performed as described for THP-1 cells.
THP-1 adhesion assays. For HBEC adhesion assays, HBEC were seeded onto 13 mm coverslips and 
allowed to form monolayers. After 48 hours 100,000 THP-1 cells stained with Cell TrackerTM Orange (Molecular 
Probes, UK) were added to the monolayers in RPMI supplemented with 10% FBS. THP-1 cells were allowed to 
adhere to HBEC monolayers for 24 hours before fixation and immunostaining with Phalloidin-633. A total of 5 
5 × 5 tile-scans per sample were obtained using a 40x air objective on a Nikon A1R confocal microscope. The tiles 
were assembled together using Nikon NIS Elements software and further analysed using Cell Profiler (BD, UK) 
to count the number of adhered THP-1 cells per image.
THP-1- integration assay. HBEC were seeded onto collagen coated 12 well plates and allowed to form 
monolayers over 3–4 days. THP-1 were stained with Cell TrackerTM Orange (Molecular Probes, UK) before add-
ing to the monolayers in RPMI supplemented with 10% FBS and fixation with formaldehyde (final concentration 
4%) added directly to the medium 4 or 6 hours after addition of THP-1. Where appropriate, HBEC monolayers 
were incubated with 10 ng/ml TNFα that was removed prior to addition of THP-1. For TNFR1 inhibitor experi-
ments, TNFR1 blocking antibody (Mab225, R&D Systems, UK) was added to HBEC monolayers for 30 min prior 
to removal of excess antibody and addition of THP-1 cells. Phase and red channel images were acquired using 
a 20x air objective on an Olympus IX71 inverted widefield microscope. 5 images were taken per well. Adherent 
THP-1 were identified using the red channel image and analysed as phase dark (integrated into the monolayer) 
and phase bright (not integrated). Data from 5 images per condition were averaged per experiment and presented 
as mean + /− SEM. Experiments were repeated 3 times and a representative data set is shown.
FITC-dextran permeability assays. Cells were seeded in 6.5 mm collagen coated Transwell chambers 
(Corning) with 8.0 μm pores at 100,000 cells per well. Wells were reviewed after 24 hrs to ensure an even covering 
of cells with a stable complete monolayer. TNFα was added to the specific treatment wells, followed by 10 μ l of 
FITC-dextran (20 KDa; Sigma) solution added to the upper chamber of all wells. 100 μ l of the media was then 
collected from the lower chamber at 30 minutes and one hour after addition of FITC-dextran. The collected 
samples were then compared for relative FITC-dextran concentration on a Fluostar Omega fluorescence plate 
reader (BMG). The system compared light absorption from each sample to provide a comparative reading of light 
transmission between the samples.
Acute inflammation mouse model. C57BL/6 (B6) mice (Harlan) were used at 4–8 weeks. All experi-
ments were approved by King’s College London animal welfare committee and performed under UK Home Office 
Regulations. For mucosal sensitization 1 μ g recombinant murine TNF-α (Immunotools) was given intranasally 
in 50 μ l PBS/mouse under light inhaled anaesthesia (isoflurane). After 24 hours animals were killed and bron-
choalveolar lavage (BAL) performed using 1 ml PBS. Flow cytometry. Inflammatory cells in BAL were identified 
as described in (van Rijt et al., 2004) with addition of anti-Gr-1 to identify neutrophils (Gr-1 + CD11c-CCR3-C
D4-CD8-B220-). Antibody staining (0.1 μ g/sample, all eBioscience) was performed in PBS 1% FCS with each 
BAL sample after washing and analyzed on a FACScalibur (BD Bioscience, UK). Total cell numbers were calcu-
lated by analysis of fixed sample volumes, validated with fluorescent beads.
Chronic inflammation mouse model. For the chronic inflammatory mouse model paraffin embedded 
slides of mouse lung sections were generated from BALB/c 6-wk-old mice, sensitized by i.p. injection of 10 μ g 
OVA diluted 1:1 with adjuvant, followed by a second sensitization on day 12. At day 19, mice were challenged daily 
by oropharyngeal administration of either 400 μ g/ml OVA in 50 μ l saline or 50 μ l saline alone for 6 d, followed by 
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additional challenges on days 26, 28, 30, and 33. The mice were sacrificed on day 34. For formalin-fixed tissue, 
the left lobe was inflated with formalin and fixed in formalin overnight and then embedded in paraffin wax. The 
slides were initially heated at 75 °C to warm the paraffin. The slides were then rehydrated via a step wise process of 
2x immersion in xylene (supplied by Fisher scientific) for 10 minutes followed by 2 x immersion in 100% ethanol, 
1x immersion in 90% ethanol, 1x immersion in 70% ethanol, 1 immersion in 50% ethanol all for 5 mins each. 
Antigen retrieval was then performed in a citrate buffer at a pH of 6 in a pressure cooker for 15 minutes.
TNFR1/2 knockout mouse model. TNFR1/2KO mice were generated in the C57BL/6 background and 
have been previously published39. For the TNFR1/2KO model paraffin embedded slides of mouse lung sections 
were generated from C57BL/6 WT and TNFR1/2 KOmice, sensitized by i.p. injection of 10 μ g OVA in 150 μ l PBS 
combined 1:1 with Complete Freunds Adjuvant (containing 1 mg/ml bacterial load), followed by a second sen-
sitization on day 12 this time using Incomplete Freunds Adjuvant (without bacterial load). At day 19, mice were 
challenged with intra-nasal administration of either 10 μ g/ml OVA in 50 μ l saline or 50 μ l saline alone, followed by 
additional challenges on days 21, 23, and 24. The mice were sacrificed on day 34. For formalin-fixed tissue, the left 
lobe was inflated with formalin and fixed in formalin overnight and then embedded in paraffin wax. Slides were 
then treated as stated earlier. On lobe was frozen at − 80 °C for processing by western blot.
Statistical analysis. Results are expressed as the mean ± SEM from the specified number of experiments, 
as indicated in the figure legends. Student’s t-test or ANOVA were used to analyse statistical significance as 
appropriate.
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